6:02 PM
 | 
Oct 31, 2013
 |  BC Extra  |  Company News

Novo to start releasing clinical study reports

Novo Nordisk A/S (CSE:NVO; NYSE:NVO) disclosed in its 3Q13 earnings that starting March 1, 2014, it will make clinical study reports publicly available for trials completed after Jan. 1, 2006, for products approved in both the U.S. and the EU. The company also said it will make available to researchers "with legitimate and valid research proposals" raw data from...

Read the full 280 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >